Clik here to view.
Stemina Earns $10M EPA Contract
Stemina Biomarker Discovery announced this week it received a five-year contract worth $10,637,000 from the U.S. Environmental Protection Agency (EPA) in conjunction with the federal agency’s ToxCast...
View ArticleClik here to view.
Stemina Lands $2.3M for Autism Study
The Nancy Lurie Marks Family Foundation is investing $2.3 million to support Stemina Biomarker Discovery‘s clinical study of biomarkers in the blood of children with autism spectrum disorders (ASD),...
View ArticleClik here to view.
Stemina Receives $2.7M Grant
Stemina Biomarker Discovery Inc., a company focused on diagnosis and individualized treatment of neurological disorders, received a $2.7 million grant from the National Institute of Mental Health...
View ArticleClik here to view.
Stemina Rebrands Its Diagnostics
Stemina Biomarker Discovery Inc., is rebranding its diagnostics to more accurately represent its focus on neurological disorders, the company announced recently. According to a release, NeuroPointDX, a...
View ArticleClik here to view.
NeuroPointDX, Ovid Therapeutics Collaborate
NeuroPointDX, the diagnostics division of Stemina Biomarker Discovery, and New York-based Ovid Therapeutics announced today they will team up to identify novel biomarkers of a rare genetic disorder...
View ArticleClik here to view.
Stemina Prepares for Commercialization
Stemina Biomarker Discovery is preparing to go to market in early 2018 with its autism diagnostic test panel, the company announced recently. According to a release, Heiner Dreismann, the former head...
View ArticleClik here to view.
NeuroPointDX Validates Autism Test
NeuroPointDX, the diagnostics division of Stemina Biomarker Discover, has validated a first-generation autism diagnostic blood test panel in its Children’s Autism Metabolome Project (CAMP) clinical...
View ArticleClik here to view.
Stemina Test Predicts Drug Cardiovascular Toxicity
Stemina Biomarker Discovery’s recent study on cardiovascular toxicity was published in the Toxicological Sciences journal this month, the company announced recently. According to a release, the study...
View ArticleClik here to view.
Stemina Test Predicts Developmental Toxicity
Stemina Biomarker Discovery announced today that its decTOX quickPredict (devTOXqP) screening platform was able to predict with high accuracy developmental toxicity in humans. The study, which...
View Article
